Lucid Diagnostics (LUCD) Enterprise Value (2022 - 2025)
Historic Enterprise Value for Lucid Diagnostics (LUCD) over the last 4 years, with Q3 2025 value amounting to -$47.3 million.
- Lucid Diagnostics' Enterprise Value fell 22667.54% to -$47.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$47.3 million, marking a year-over-year decrease of 22667.54%. This contributed to the annual value of -$22.4 million for FY2024, which is 1832.13% down from last year.
- Lucid Diagnostics' Enterprise Value amounted to -$47.3 million in Q3 2025, which was down 22667.54% from -$31.1 million recorded in Q2 2025.
- Over the past 5 years, Lucid Diagnostics' Enterprise Value peaked at -$14.5 million during Q3 2024, and registered a low of -$47.9 million during Q1 2022.
- Its 4-year average for Enterprise Value is -$29.0 million, with a median of -$25.2 million in 2025.
- As far as peak fluctuations go, Lucid Diagnostics' Enterprise Value surged by 3975.47% in 2024, and later plummeted by 22667.54% in 2025.
- Quarter analysis of 4 years shows Lucid Diagnostics' Enterprise Value stood at -$22.5 million in 2022, then rose by 15.92% to -$18.9 million in 2023, then decreased by 18.32% to -$22.4 million in 2024, then plummeted by 111.7% to -$47.3 million in 2025.
- Its Enterprise Value stands at -$47.3 million for Q3 2025, versus -$31.1 million for Q2 2025 and -$25.2 million for Q1 2025.